Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
Background. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine sulfate (GS) in the treatment of osteoarthritis puts forward increased requirements for the safety of drugs, primarily in terms of effects on the liver and kidneys.Objective: systematization of data on t...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
IRBIS LLC
2022-01-01
|
| Series: | Фармакоэкономика |
| Assuntos: | |
| Acceso en liña: | https://www.pharmacoeconomics.ru/jour/article/view/630 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|